The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Browne L Daniel since 2014.
The trader's CIK number is 1597583.
At the time of the last reporting, Browne L Daniel was the CEO and President of Revance Therapeutics, Inc.. (stock ticker symbol RVNC).
Also see all insider trading activities at Revance Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | RVNC | 0 | $0 | 17,059 | $276,356 | 0 | $0 |
| 2018 | RVNC | 0 | $0 | 33,735 | $1,061,649 | 20,000 | $51,000 |
| 2017 | RVNC | 0 | $0 | 100,699 | $2,202,505 | 13,631 | $34,759 |
| 2016 | RVNC | 0 | $0 | 36,000 | $648,816 | 12,045 | $30,714 |
| 2014 | RVNC | 6,000 | $100,020 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-03-18 | RVNC | Sale | 11,613 | 15.51 | 180,071 |
| 2019-02-19 | RVNC | Sale | 5,446 | 17.68 | 96,285 |
| 2018-03-16 | RVNC | Option Ex | 20,000 | 2.55 | 51,000 |
| 2018-03-15 | RVNC | Sale | 1,000 | 32.80 | 32,800 |
| 2018-03-16 | RVNC | Sale | 5,452 | 31.43 | 171,345 |
| 2018-03-07 | RVNC | Sale | 27,283 | 31.43 | 857,504 |
| 2017-11-22 | RVNC | Sale | 7,600 | 24.94 | 189,566 |
| 2017-10-18 | RVNC | Sale | 7,662 | 26.16 | 200,407 |
| 2017-09-20 | RVNC | Sale | 7,600 | 23.58 | 179,185 |
| 2017-08-23 | RVNC | Option Ex | 331 | 2.55 | 844 |
| 2017-08-23 | RVNC | Sale | 22,800 | 22.77 | 519,042 |
| 2017-06-12 | RVNC | Option Ex | 8,300 | 2.55 | 21,165 |
| 2017-05-30 | RVNC | Option Ex | 5,000 | 2.55 | 12,750 |
| 2017-05-24 | RVNC | Sale | 19,713 | 20.35 | 401,100 |
| 2017-05-22 | RVNC | Sale | 12,287 | 20.20 | 248,160 |
| 2017-02-22 | RVNC | Sale | 11,037 | 20.63 | 227,649 |
| 2017-01-25 | RVNC | Sale | 12,000 | 19.78 | 237,396 |
| 2016-12-28 | RVNC | Sale | 12,000 | 20.94 | 251,256 |
| 2016-11-25 | RVNC | Sale | 12,000 | 18.28 | 219,360 |
| 2016-10-26 | RVNC | Sale | 12,000 | 14.85 | 178,200 |
| 2015-12-30 | RVNC | Option Ex | 12,045 | 2.55 | 30,714 |
| 2014-11-28 | RVNC | Buy | 6,000 | 16.67 | 100,020 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Browne L Daniel (CEO and President of Revance Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.